In fact, the presence of angiogenic molecules, such as vascular endothelial growth factor (VEGF) and angiopoietin 2 (ANG2), within the TME may better drive immune cells towards the tumor, by altering the expression of adhesion molecules on endothelial cells (ECs) and immune cells [46]. The gene discussed is VEGFA; the disease is neoplasm.